Hap Trading, LLC Immuno Gen, Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $1.25 Million - $3 Million	100,000 New	100,000 $9.34 Million
Q1 2022 May 12, 2022	SELL	$4.26 - $7.48 $32,376 - $56,848	-7,600 Reduced 41.53%	10,700 $5,000
Q1 2019 May 10, 2019	BUY	$2.41 - $5.91 $44,103 - $108,153	18,300 New	18,300 $22,000
Q3 2018 Nov 09, 2018	SELL	$8.6 - $11.26 $141,900 - $185,790	-16,500 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$9.52 - $12.15 $1.56 Million - $1.99 Million	-164,000 Reduced 90.86%	16,500 $5,000
Q1 2018 May 11, 2018	BUY	$6.7 - $12.95 $1.21 Million - $2.34 Million	180,500 New	180,500 $129,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.